FMSDX
Price
$13.83
Change
+$0.06 (+0.44%)
Updated
May 8 closing price
Net Assets
2.74B
RLBEX
Price
$34.31
Change
+$0.05 (+0.15%)
Updated
May 8 closing price
Net Assets
234.05B
Ad is loading...

FMSDX vs RLBEX

Header iconFMSDX vs RLBEX Comparison
Open Charts FMSDX vs RLBEXBanner chart's image
Fidelity Multi-Asset Income
Price$13.83
Change+$0.06 (+0.44%)
VolumeN/A
Net Assets2.74B
American Funds American Balanced R4
Price$34.31
Change+$0.05 (+0.15%)
VolumeN/A
Net Assets234.05B
FMSDX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FMSDX vs. RLBEX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMSDX is a Buy and RLBEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 234B vs. FMSDX (2.74B). FMSDX pays higher dividends than RLBEX: FMSDX (3.97) vs RLBEX (1.98). FMSDX was incepted earlier than RLBEX: FMSDX (7 years) vs RLBEX (23 years). FMSDX (0.80) is less costly to investors than RLBEX (0.59). FMSDX is a more actively managed with annual turnover of: 230.00 vs. RLBEX (44.00). FMSDX has a lower initial minimum investment than RLBEX: FMSDX (0) vs RLBEX (250). RLBEX annual gain was more profitable for investors over the last year : 4.73 vs. FMSDX (4.32). FMSDX return over 5 years is better than : 50.77 vs. RLBEX (36.69).
FMSDXRLBEXFMSDX / RLBEX
Total Expense Ratio0.800.59136%
Annual Report Gross Expense Ratio0.800.59136%
Fund Existence7 years23 years-
Gain YTD-1.3590.425-320%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.74B234B1%
Annual Yield % from dividends3.971.98201%
Returns for 1 year4.324.7391%
Returns for 3 years20.2521.8493%
Returns for 5 years50.7736.69138%
Returns for 10 yearsN/A52.56-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIEGX10.63N/A
N/A
BNY Mellon Emerging Markets Inv
LGOPX22.77N/A
N/A
Lord Abbett Growth Opportunities P
SAMVX11.16N/A
N/A
Virtus Ceredex Mid-Cap Value Equity A
GMNCX10.18N/A
N/A
Gabelli Global Mini Mites C
VSRAX21.12N/A
N/A
Invesco Small Cap Value R